Hacker News new | past | comments | ask | show | jobs | submit login

I had a look at your trial description (https://clinicaltrials.gov/study/NCT06424912)

Are you planning to publish the longitudinal data, esp. of endpoints 2 and 3 (prostate size, urinary flow). It would greatly add to the public understanding of this procedure. Why didn't you go for PSA? It's easy to obtain altough one probably wouldn't expect significant changes in this short time frame.






Yes, that’s the intent post study completion.

We are collecting PSA data as well. It’s a useful parameter for prostate cancer.




Join us for AI Startup School this June 16-17 in San Francisco!

Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: